Skip to NavigationSkip to content

News

0
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared with 2018, while...
0
Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis in children...
0
The FDA has made MDMA treatment for PTSD more accessible by putting it on its Expanded Access program.
0
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed to meet its...

Features

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...